Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "Membranous nephropathy"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting MEmbranous Nephropathy Trial Of Rituximab
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: Rituximab;   Drug: Cyclosporine
2 Withdrawn Aliskiren in Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Aliskiren
3 Recruiting Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
Condition: MEMBRANOUS NEPHROPATHY
Interventions: Drug: TACROLIMUS;   Drug: RITUXIMAB;   Drug: METHYLPREDNISOLONE;   Drug: CYCLOPHOSPHAMIDE
4 Active, not recruiting Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin);   Drug: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
5 Completed Rituximab in Membranous Nephropathy
Condition: Membranous Nephropathy
Intervention: Drug: Rituximab
6 Active, not recruiting Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: Losartan Tablets & QingReMoShen Granule;   Drug: Losartan Tablets & Placebo Granule
7 Completed Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Condition: Membranous Nephropathy
Intervention: Drug: Rituximab
8 Recruiting Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
Condition: Membranous Nephropathy
Intervention: Procedure: Blood and urine analysis
9 Completed Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: tetracosactide hexacetaat
10 Completed Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: ACTH
11 Unknown  Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine;   Drug: The immunosuppressive agents
12 Completed Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: Cyclophosphamide and steroids
13 Completed Mycophenolate Mofetil in Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: mycophenolate mofetil orally 1000 mg twice a day (BID);   Drug: prednisone 0,5 mg/kg orally on alternate days;   Drug: intravenous (i.v.) methylprednisolone 1000 mg, total 9
14 Completed To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
Condition: Membranous Nephropathy
Intervention: Drug: TW
15 Recruiting Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Mycophenolate mofetil, low dose steroid;   Drug: Cyclosporin, low dose steroid
16 Completed Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Tacrolimus
17 Completed Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: Tripterygium wilfordii;   Drug: FK506
18 Active, not recruiting Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Conditions: Proteinuria;   Idiopathic Membranous Nephropathy
Interventions: Drug: Repository Corticotropin Injection;   Drug: Placebo
19 Withdrawn Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Belimumab 10 mg;   Drug: Placebo
20 Not yet recruiting Study on the Therapeutic Effect of TCM Treatment for MDR MN
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Jianpixiaozhong particles and Wuse Dietotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.